[1]
A. Naidoo, “Survival in sight: Rethinking PDE5 inhibitors in ILD-associated pulmonary hypertension”, Afr J Thoracic Crit Care Med, vol. 31, no. 4, p. e2720, Dec. 2025, doi: 10.7196/.